Literature DB >> 33987226

countfitteR: efficient selection of count distributions to assess DNA damage.

Jarosław Chilimoniuk1,2, Alicja Gosiewska3, Jadwiga Słowik3, Romano Weiss2, P Markus Deckert4, Stefan Rödiger2,5, Michał Burdukiewicz2,6.   

Abstract

BACKGROUND: DNA double-strand breaks can be counted as discrete foci by imaging techniques. In personalized medicine and pharmacology, the analysis of counting data is relevant for numerous applications, e.g., for cancer and aging research and the evaluation of drug efficacy. By default, it is assumed to follow the Poisson distribution. This assumption, however, may lead to biased results and faulty conclusions in datasets with excess zero values (zero-inflation), a variance larger than the mean (overdispersion), or both. In such cases, the assumption of a Poisson distribution would skew the estimation of mean and variance, and other models like the negative binomial (NB), zero-inflated Poisson or zero-inflated NB distributions should be employed. The model chosen has an influence on the parameter estimation (mean value and confidence interval). Yet the choice of the suitable distribution model is not trivial.
METHODS: To support, simplify and objectify this process, we have developed the countfitteR software as an R package. We used a Bayesian approach for distribution model selection and the shiny web application framework for interactive data analysis.
RESULTS: We show the application of our software based on examples of DNA double-strand break count data from phenotypic imaging by multiplex fluorescence microscopy. In analyzing numerous datasets of molecular pharmacological markers (phosphorylated histone H2AX and p53 binding protein), countfitteR demonstrated an equal or superior statistical performance compared to the usually employed two-step procedure, with an overall power of up to 98%. In addition, it still gave information in cases with no result at all from the two-step procedure. In our data sample we found that the NB distribution was the most frequent, with the Poisson distribution taking second place.
CONCLUSIONS: countfitteR can perform an automated distribution model selection and thus support the data analysis and lead to objective statistically verifiable estimated values. Originally designed for the analysis of foci in biomedical image data, countfitteR can be used in a variety of areas where non-Poisson distributed counting data is prevalent. 2021 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  DNA damage; count data; overdispersion; zero-inflation

Year:  2021        PMID: 33987226      PMCID: PMC8105836          DOI: 10.21037/atm-20-6363

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  42 in total

Review 1.  Limitations associated with analysis of cytogenetic data for biological dosimetry.

Authors:  Volodymyr A Vinnikov; Elizabeth A Ainsbury; Nataliya A Maznyk; David C Lloyd; Kai Rothkamm
Journal:  Radiat Res       Date:  2010-10       Impact factor: 2.841

2.  High-content phenotypic profiling of drug response signatures across distinct cancer cells.

Authors:  Peter D Caie; Rebecca E Walls; Alexandra Ingleston-Orme; Sandeep Daya; Tom Houslay; Rob Eagle; Mark E Roberts; Neil O Carragher
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

Review 3.  Biomarkers: potential uses and limitations.

Authors:  Richard Mayeux
Journal:  NeuroRx       Date:  2004-04

4.  Statistical Methods for Unusual Count Data: Examples From Studies of Microchimerism.

Authors:  Katherine A Guthrie; Hilary S Gammill; Mads Kamper-Jørgensen; Anne Tjønneland; Vijayakrishna K Gadi; J Lee Nelson; Wendy Leisenring
Journal:  Am J Epidemiol       Date:  2016-11-15       Impact factor: 4.897

5.  In-depth mining of clinical data: the construction of clinical prediction model with R.

Authors:  Zhi-Rui Zhou; Wei-Wei Wang; Yan Li; Kai-Rui Jin; Xuan-Yi Wang; Zi-Wei Wang; Yi-Shan Chen; Shao-Jia Wang; Jing Hu; Hui-Na Zhang; Po Huang; Guo-Zhen Zhao; Xing-Xing Chen; Bo Li; Tian-Song Zhang
Journal:  Ann Transl Med       Date:  2019-12

6.  Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.

Authors:  P H Clingen; J Y-H Wu; J Miller; N Mistry; F Chin; P Wynne; K M Prise; J A Hartley
Journal:  Biochem Pharmacol       Date:  2008-04-16       Impact factor: 5.858

7.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

Authors:  Chun-Chin Chen; Weiran Feng; Pei Xin Lim; Elizabeth M Kass; Maria Jasin
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

8.  Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker.

Authors:  Christophe E Redon; Asako J Nakamura; Olga A Martin; Palak R Parekh; Urbain S Weyemi; William M Bonner
Journal:  Aging (Albany NY)       Date:  2011-02       Impact factor: 5.682

9.  rEHR: An R package for manipulating and analysing Electronic Health Record data.

Authors:  David A Springate; Rosa Parisi; Ivan Olier; David Reeves; Evangelos Kontopantelis
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

Review 10.  From Big Data to Precision Medicine.

Authors:  Tim Hulsen; Saumya S Jamuar; Alan R Moody; Jason H Karnes; Orsolya Varga; Stine Hedensted; Roberto Spreafico; David A Hafler; Eoin F McKinney
Journal:  Front Med (Lausanne)       Date:  2019-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.